Pierre Bombaron

6.0k citations
27 papers · 5.0k · 1 hit paper · h-index 10

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 1%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Lung Cancer Treatments and Mutations 10
    • Lung Cancer Diagnosis and Treatment 3
    • Cancer Immunotherapy and Biomarkers 6
    • Colorectal Cancer Treatments and Studies 4
    • Global Cancer Incidence and Screening 2

Pierre Bombaron

27 papers receiving 4.9k citations

Pierre Bombaron's Hit Papers

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial 2012 · 4.7k citations
4.7k0+4+9Years since publication10002.0k3.0k4.0k

Peers

Pierre Bombaron
Comparison fields: 5 of 88
  • Pulmonary and Respiratory Medicine 3.8k
  • Oncology 2.2k
  • Cancer Research 745
  • Molecular Biology 944
  • Pathology and Forensic Medicine 182
Replace Ramón García-Gómez with:
Ramón García-Gómez Spain
Ulpiano Jiménez Spain
Alfonso Illiano Italy
Haruto Hirano Japan
Javier Valdivia Spain
María Sanchez-Ronco Spain
Itziar de Aguirre Spain
Songwen Zhou China
Changli Wang China
Miguel Ángel Moreno Spain
Pierre Bombaron relative to Ramón García-Gómez Spain Ramón García-Gómez's profile →
Citations per field
00.5×1.5×
Ramón García-Gómez · 1×
Citations per year

Countries citing papers authored by Pierre Bombaron

Since Specialization
Citations

This map shows the geographic impact of Pierre Bombaron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Bombaron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Bombaron more than expected).

Fields of papers citing papers by Pierre Bombaron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Bombaron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Bombaron. The network helps show where Pierre Bombaron may publish in the future.

Co-authors

The 25 scholars most cited alongside Pierre Bombaron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pierre Bombaron Line = papers co-authored together Pierre Bombaron links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Hit paper breakdown →
20124725
2 202354
3 200641
4 202033
5 200232
6 201021
7 200420
8 200520
9 202118
10 200715
11 199710
12 19978
13 20227
14 20247
15 20105
16 19994
17 20194
18
[Chemotherapy in elderly patients with bronchogenic cancers].
19963
19 20193
20
[Spontaneous hydro-pneumothorax disclosing malignant mesothelioma. Apropos of 2 cases].
19962

About Pierre Bombaron

Pierre Bombaron is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Economics and Econometrics and Epidemiology, having authored 27 papers that have together received 5.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Cancer Immunotherapy and Biomarkers (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Multiple and Secondary Primary Cancers (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Economic and Financial Impacts of Cancer (3 papers), Global Cancer Incidence and Screening (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.8k citations), Oncology (2.2k citations), Cancer Research (745 citations), Molecular Biology (944 citations) and Pathology and Forensic Medicine (182 citations). Pierre Bombaron has collaborated with scholars based in France, United Kingdom and Germany. Frequent co-authors include Maurice Pérol, Pierre Jean Souquet, Laurence Geriniere, P. Fournel, G. Robinet, Lionel Falchero, Henri Berard, H. Léna, Alexis Benjamin Cortot and François Blanchon. Their work appears in journals such as Lung Cancer, Annals of Oncology, OncoImmunology, Journal of Thoracic Oncology and Future Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact